brentuximab,Dacarbazine,Doxorubicin Hydrochloride,Filgrastim,Nivolumab,Pegfilgrastim,Vinblastine Sulfate
seagen,amgen,Bms
['lymsm']
trial and patient characteristics a nicely-designed trial #asco23 #lymsm 
haematology registrar | @harvardmed fellow @PORTAL_research | evidence-based medicine & policy | lymphoma | myeloma | Fulbright | writer | SoMe Ed @BrJHaem